FRANCISCO JAVIER
LÓPEZ LONGO
Chercheur jusqu {1}
Universidad Autónoma de Madrid
Madrid, EspañaPublications en collaboration avec des chercheurs de Universidad Autónoma de Madrid (30)
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)
Lupus, Vol. 29, Núm. 1, pp. 27-36
-
Insights into the procoagulant profile of patients with systemic lupus erythematosus without antiphospholipid antibodies
Journal of Clinical Medicine, Vol. 9, Núm. 10, pp. 1-17
2019
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
Journal of Clinical Medicine, Vol. 8, Núm. 11
-
Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease
Clinical Rheumatology, Vol. 38, Núm. 3, pp. 803-815
-
Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 48, Núm. 6, pp. 1025-1029
2018
-
Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugs
Rheumatology International, Vol. 38, Núm. 8, pp. 1465-1470
2017
-
Juvenile- and adult-onset systemic lupus erythematosus: A comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
Clinical and Experimental Rheumatology, Vol. 35, Núm. 6, pp. 1047-1055
2016
-
Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)
Medicine (United States), Vol. 95, Núm. 9
-
Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus
Clinical and Experimental Rheumatology, Vol. 34, pp. 40-47
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
-
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry
Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250
-
The feet in systemic lupus erythematosus; are we underestimating their involvement and functional impact?
Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 609-617
-
To what extent is foot pain related to biomechanical changes and ultrasound-detected abnormalities in rheumatoid arthritis?
Clinical and Experimental Rheumatology, Vol. 34, Núm. 3, pp. 480-488
2015
-
Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus
Lupus, Vol. 24, Núm. 7, pp. 720-729
-
Cardiovascular events in systemic lupus erythematosus: A Nationwide Study in Spain from the RELESSER Registry
Medicine (United States), Vol. 94, Núm. 29
-
Comparison of two ELISA versions for infliximab serum levels in patients diagnosed with ankylosing spondylitis
Rheumatology International, Vol. 35, Núm. 6, pp. 1021-1025
-
Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the spanish rheumatology society lupus registry (RELESSER) with emphasis on complete versus incomplete lupus differences
Medicine (United States), Vol. 94, Núm. 1, pp. e267
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35